Sanofi €320M Licensing Deal for Rare Cancer Treatment

0
45

RadioMedix CEO Ebrahim S. Delpassand highlighted the potential of AlphaMedix, noting that the partnership with Sanofi aims to bring the therapy to more patients globally.

Sanofi €320M Licensing Deal : Legal and Financial Advisors

Orano Med is being advised by McDermott Will & Emery LLP on legal matters, while Moelis & Co. is providing financial guidance. Counsel for Sanofi and RadioMedix was not immediately available.